InvestorsHub Logo
Followers 9
Posts 2033
Boards Moderated 0
Alias Born 08/26/2010

Re: Bungler post# 156957

Saturday, 01/18/2014 10:47:47 AM

Saturday, January 18, 2014 10:47:47 AM

Post# of 346050
It's pretty amazing that the trial which some still are compelled to refer to as "botched" resulted in FDA Phase III approval and Fast Track Designation, huh? If the data had not been "botched" most likely Bavi would have been already approved, wouldn't you agree?

We shall see, maybe. But is mgmt supposed to get a prize for where we are now? At best case scenario right now we are 15 months behind where we would have been. Only time will tell what will happen. Obviously the reconstituted data is not as good as it was or after 15 months we wouldn't still be at $1.72 and without a partner when we were over $5 with a supposedly partner lined up and a loan. How anyone can make the assumption that we would be approved already and yet mgmt can't get a partner or a financing is ludicrous.

Yes it is remarkable that we have gotten this far after the mix up but it by no means dictates that everything is the same now. The stock is still at $1.72 and as someone already said the stock needs to be at least $17 just to compare to an average stock gain if you invested in a mutual fund. This stock alone was $3.20 before the RS over 4 years ago. Can't get excited about a stock price of $1.72 can we after all this? All imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News